The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K
Danijela Maksimović‐Ivanić(University of Belgrade), Marija Mojić(Institute for Biological Research “Siniša Stanković”), Mirna Bulatović(Institute for Biological Research “Siniša Stanković”), Milica Radojković(University of Belgrade), Miloš Kuzmanović(University of Belgrade), Slobodan Ristić(University of Belgrade), Stanislava Stošić‐Grujičić(Institute for Biological Research “Siniša Stanković”), Djordje Miljković(University of Belgrade), Eugenio Cavalli(University of Catania), Massimo Libra(University of Catania), Paolo Fagone(University of Catania), James A. McCubrey(East Carolina University), Ferdinando Nicoletti(University of Catania), Sanja Mijatović(Institute for Biological Research “Siniša Stanković”)
Cited by 27